I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 28% ± 11% | |
| fibroblast | 12 studies | 25% ± 9% | |
| astrocyte | 11 studies | 29% ± 14% | |
| oligodendrocyte | 9 studies | 29% ± 10% | |
| oligodendrocyte precursor cell | 8 studies | 29% ± 14% | |
| macrophage | 7 studies | 25% ± 6% | |
| epithelial cell | 7 studies | 41% ± 21% | |
| adipocyte | 7 studies | 23% ± 4% | |
| microglial cell | 6 studies | 26% ± 8% | |
| retinal cone cell | 6 studies | 30% ± 13% | |
| endothelial cell of lymphatic vessel | 6 studies | 29% ± 9% | |
| GABAergic neuron | 6 studies | 38% ± 21% | |
| type I pneumocyte | 6 studies | 27% ± 9% | |
| glutamatergic neuron | 5 studies | 44% ± 22% | |
| neuron | 5 studies | 36% ± 13% | |
| club cell | 5 studies | 24% ± 8% | |
| smooth muscle cell | 5 studies | 23% ± 3% | |
| interneuron | 5 studies | 36% ± 21% | |
| B cell | 4 studies | 18% ± 2% | |
| ciliated cell | 4 studies | 27% ± 6% | |
| lymphocyte | 4 studies | 26% ± 6% | |
| retina horizontal cell | 4 studies | 19% ± 3% | |
| retinal rod cell | 4 studies | 22% ± 6% | |
| abnormal cell | 4 studies | 26% ± 8% | |
| connective tissue cell | 4 studies | 17% ± 2% | |
| pericyte | 4 studies | 23% ± 6% | |
| basal cell | 4 studies | 38% ± 26% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 16% ± 0% | |
| capillary endothelial cell | 3 studies | 18% ± 3% | |
| glial cell | 3 studies | 19% ± 1% | |
| secretory cell | 3 studies | 17% ± 1% | |
| endothelial cell of vascular tree | 3 studies | 27% ± 11% | |
| natural killer cell | 3 studies | 20% ± 2% | |
| adventitial cell | 3 studies | 18% ± 3% | |
| T cell | 3 studies | 21% ± 1% | |
| myofibroblast cell | 3 studies | 24% ± 6% | |
| goblet cell | 3 studies | 31% ± 19% | |
| mast cell | 3 studies | 18% ± 2% |
